Literature DB >> 25326880

Do We Need Worms to Promote Immune Health?

Joel V Weinstock1.   

Abstract

Many immune-mediated diseases like inflammatory bowel disease, multiple sclerosis, type 1 diabetes, asthma, and food allergy appeared to have increased in frequency in developed countries in the latter part of the twentieth century. Reports from less developed countries suggest that the "epidemic" of immune-mediated diseases now is spreading into these regions as well. The "hygiene hypothesis" was developed to partly explain this phenomenon. It has been proposed that modern-day sanitary living has altered our exposure to organisms that provided protection from these diseases in the past. Alternations in the composition of our intestinal flora and fauna could play a role. Helminths are a group of worm-like parasitic organisms that have adapted to live in various regions of their hosts. Epidemiological and some clinical data suggest that these organisms can protect people from developing immune-mediated diseases. Animal experimentation has shown that helminths stimulate the production of regulatory cytokines, activate regulatory T cells, and induce regulatory dendritic cells and macrophages. This could be the mechanism by which they protect the host from these diseases. Early clinical studies also suggest that helminths may prove useful for treating immunological diseases. More sophisticated clinical studies are underway, testing live helminth agents as therapeutic agents. Also, a strong effort is ongoing to discover the agents produced by helminths that modulate host immune responses with an eye on developing new, highly effective immune modulatory therapeutic agent.

Entities:  

Keywords:  Autoimmunity; C-type lectin receptors; Dendritic cells; Helminths; Inflammatory bowel disease; Macrophage; Treg

Mesh:

Substances:

Year:  2015        PMID: 25326880     DOI: 10.1007/s12016-014-8458-3

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   8.667


  44 in total

Review 1.  Why does the north-south gradient of incidence of multiple sclerosis seem to have disappeared on the northern hemisphere?

Authors:  Nils Koch-Henriksen; Per Soelberg Sorensen
Journal:  J Neurol Sci       Date:  2011-10-07       Impact factor: 3.181

2.  Is there a role for helminths in the therapy of inflammatory bowel disease?

Authors:  Robert W Summers; David E Elliott; Joel V Weinstock
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2005-02

3.  A proof of concept study establishing Necator americanus in Crohn's patients and reservoir donors.

Authors:  J Croese; J O'neil; J Masson; S Cooke; W Melrose; D Pritchard; R Speare
Journal:  Gut       Date:  2006-01       Impact factor: 23.059

4.  Helminths as governors of inflammatory bowel disease.

Authors:  J Büning; N Homann; D von Smolinski; F Borcherding; F Noack; M Stolte; M Kohl; H Lehnert; D Ludwig
Journal:  Gut       Date:  2008-08       Impact factor: 23.059

Review 5.  Environmental factors and their timing in adult-onset multiple sclerosis.

Authors:  Adam E Handel; Gavin Giovannoni; George C Ebers; Sreeram V Ramagopalan
Journal:  Nat Rev Neurol       Date:  2010-02-16       Impact factor: 42.937

6.  Poor sanitation and helminth infection protect against skin sensitization in Vietnamese children: A cross-sectional study.

Authors:  Carsten Flohr; Luc Nguyen Tuyen; Sarah Lewis; Rupert Quinnell; Truong Tan Minh; Ho Thanh Liem; Jim Campbell; David Pritchard; Tran Tinh Hien; Jeremy Farrar; Hywel Williams; John Britton
Journal:  J Allergy Clin Immunol       Date:  2006-10-13       Impact factor: 10.793

7.  Independent effects of intestinal parasite infection and domestic allergen exposure on risk of wheeze in Ethiopia: a nested case-control study.

Authors:  S Scrivener; H Yemaneberhan; M Zebenigus; D Tilahun; S Girma; S Ali; P McElroy; A Custovic; A Woodcock; D Pritchard; A Venn; J Britton
Journal:  Lancet       Date:  2001-11-03       Impact factor: 79.321

8.  Intestinally secreted C-type lectin Reg3b attenuates salmonellosis but not listeriosis in mice.

Authors:  Marleen T J van Ampting; Linda M P Loonen; Arjan J Schonewille; Irene Konings; Carolien Vink; Juan Iovanna; Mathias Chamaillard; Jan Dekker; Roelof van der Meer; Jerry M Wells; Ingeborg M J Bovee-Oudenhoven
Journal:  Infect Immun       Date:  2012-01-17       Impact factor: 3.441

9.  Geographic variation of inflammatory bowel disease within the United States.

Authors:  A Sonnenberg; D J McCarty; S J Jacobsen
Journal:  Gastroenterology       Date:  1991-01       Impact factor: 22.682

10.  Helminth infections decrease host susceptibility to immune-mediated diseases.

Authors:  Joel V Weinstock; David E Elliott
Journal:  J Immunol       Date:  2014-10-01       Impact factor: 5.422

View more
  12 in total

Review 1.  Nematodes and human therapeutic trials for inflammatory disease.

Authors:  D E Elliott; J V Weinstock
Journal:  Parasite Immunol       Date:  2017-04-18       Impact factor: 2.280

2.  Downregulation of the Syk Signaling Pathway in Intestinal Dendritic Cells Is Sufficient To Induce Dendritic Cells That Inhibit Colitis.

Authors:  Long Hang; Arthur M Blum; Sangeeta Kumar; Joseph F Urban; Makedonka Mitreva; Timothy G Geary; Armando Jardim; Mary M Stevenson; Clifford A Lowell; Joel V Weinstock
Journal:  J Immunol       Date:  2016-08-24       Impact factor: 5.422

3.  Safety and efficacy of helminth treatment in relapsing-remitting multiple sclerosis: Results of the HINT 2 clinical trial.

Authors:  John Fleming; Gianna Hernandez; Leslie Hartman; Jane Maksimovic; Sara Nace; Benjamin Lawler; Todd Risa; Thomas Cook; Rashmi Agni; Mark Reichelderfer; Christopher Luzzio; Loren Rolak; Aaron Field; Zsuzsanna Fabry
Journal:  Mult Scler       Date:  2017-10-24       Impact factor: 6.312

Review 4.  Linking the Microbiota, Chronic Disease, and the Immune System.

Authors:  Timothy W Hand; Ivan Vujkovic-Cvijin; Vanessa K Ridaura; Yasmine Belkaid
Journal:  Trends Endocrinol Metab       Date:  2016-09-10       Impact factor: 12.015

Review 5.  The Eosinophil in Health and Disease: from Bench to Bedside and Back.

Authors:  Wei Liao; Hai Long; Christopher Chia-Chi Chang; Qianjin Lu
Journal:  Clin Rev Allergy Immunol       Date:  2016-04       Impact factor: 8.667

Review 6.  Autoimmunity in 2015.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2016-08       Impact factor: 8.667

Review 7.  Modulating Composition and Metabolic Activity of the Gut Microbiota in IBD Patients.

Authors:  Mario Matijašić; Tomislav Meštrović; Mihaela Perić; Hana Čipčić Paljetak; Marina Panek; Darija Vranešić Bender; Dina Ljubas Kelečić; Željko Krznarić; Donatella Verbanac
Journal:  Int J Mol Sci       Date:  2016-04-19       Impact factor: 5.923

8.  Interleukin-5 Mediates Parasite-Induced Protection against Experimental Autoimmune Encephalomyelitis: Association with Induction of Antigen-Specific CD4+CD25+ T Regulatory Cells.

Authors:  Giang T Tran; Paul L Wilcox; Lindsay A Dent; Catherine M Robinson; Nicole Carter; Nirupama D Verma; Bruce M Hall; Suzanne J Hodgkinson
Journal:  Front Immunol       Date:  2017-11-01       Impact factor: 7.561

Review 9.  Health Challenges of the Pacific Region: Insights From History, Geography, Social Determinants, Genetics, and the Microbiome.

Authors:  Paul F Horwood; Arnaud Tarantola; Cyrille Goarant; Mariko Matsui; Elise Klement; Masahiro Umezaki; Severine Navarro; Andrew R Greenhill
Journal:  Front Immunol       Date:  2019-09-13       Impact factor: 7.561

10.  Trichinella spiralis Excretory-Secretory Products Induce Tolerogenic Properties in Human Dendritic Cells via Toll-Like Receptors 2 and 4.

Authors:  Nataša Ilic; Alisa Gruden-Movsesijan; Jelena Cvetkovic; Sergej Tomic; Dragana Bozidar Vucevic; Carmen Aranzamendi; Miodrag Colic; Elena Pinelli; Ljiljana Sofronic-Milosavljevic
Journal:  Front Immunol       Date:  2018-01-24       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.